Jennifer Beam Dowd1, Allison E Aiello. 1. Hunter College, School of Health Sciences, City University of New York (CUNY), New York, NY, USA.
Abstract
BACKGROUND: Lower socioeconomic status (SES) is strongly linked to health outcomes, though the mechanisms are poorly understood. Little is known about the role of the immune system in creating and sustaining health disparities. Here we test whether SES is related to cell-mediated immunity, as measured by the host's ability to keep persistent cytomegalovirus (CMV) antibody levels in a quiescent state. METHODS: Censored regression models were used to test the cross-sectional relationship of education, income, and race/ethnicity with antibody response to CMV, using a nationally representative sample of 9721 respondents aged 25 years and older in the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994). RESULTS: Among CMV-seropositive respondents, those with less education, lower income, and nonwhite race/ethnicity had higher levels of CMV antibodies at all ages. On average, each additional year of age was associated with CMV antibody levels that were 0.03 units higher (95% confidence interval = 0.03 to 0.04), whereas each additional year of education was associated with antibody levels that were 0.05 units lower (0.02 to 0.09). A doubling of family income was associated with antibody levels that were 0.25 units lower (0.11 to 0.39), the equivalent of 8 fewer years of age-related CMV antibody response. These relationships remained strong after controlling for baseline health conditions, smoking status, and BMI. CONCLUSIONS: SES is associated with an indirect marker of cell-mediated immunity in a nationally representative sample. SES differences in immune control over CMV may have fundamental implications for health disparities over the life course.
BACKGROUND: Lower socioeconomic status (SES) is strongly linked to health outcomes, though the mechanisms are poorly understood. Little is known about the role of the immune system in creating and sustaining health disparities. Here we test whether SES is related to cell-mediated immunity, as measured by the host's ability to keep persistent cytomegalovirus (CMV) antibody levels in a quiescent state. METHODS: Censored regression models were used to test the cross-sectional relationship of education, income, and race/ethnicity with antibody response to CMV, using a nationally representative sample of 9721 respondents aged 25 years and older in the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994). RESULTS: Among CMV-seropositive respondents, those with less education, lower income, and nonwhite race/ethnicity had higher levels of CMV antibodies at all ages. On average, each additional year of age was associated with CMV antibody levels that were 0.03 units higher (95% confidence interval = 0.03 to 0.04), whereas each additional year of education was associated with antibody levels that were 0.05 units lower (0.02 to 0.09). A doubling of family income was associated with antibody levels that were 0.25 units lower (0.11 to 0.39), the equivalent of 8 fewer years of age-related CMV antibody response. These relationships remained strong after controlling for baseline health conditions, smoking status, and BMI. CONCLUSIONS: SES is associated with an indirect marker of cell-mediated immunity in a nationally representative sample. SES differences in immune control over CMV may have fundamental implications for health disparities over the life course.
Authors: Raymond P Stowe; Elena V Kozlova; Deborah L Yetman; Dennis M Walling; James S Goodwin; Ronald Glaser Journal: Exp Gerontol Date: 2007-01-30 Impact factor: 4.032
Authors: Stephanie A S Staras; Sheila C Dollard; Kay W Radford; W Dana Flanders; Robert F Pass; Michael J Cannon Journal: Clin Infect Dis Date: 2006-10-02 Impact factor: 9.079
Authors: Sven Koch; Anis Larbi; Dennis Ozcelik; Rafael Solana; Cécile Gouttefangeas; Sebastian Attig; Anders Wikby; Jan Strindhall; Claudio Franceschi; Graham Pawelec Journal: Ann N Y Acad Sci Date: 2007-10 Impact factor: 5.691
Authors: Avni H Thakore; Chao-Yu Guo; Martin G Larson; Diane Corey; Thomas J Wang; Ramachandran S Vasan; Ralph B D'Agostino; Izabella Lipinska; John F Keaney; Emelia J Benjamin; Christopher J O'Donnell Journal: Am J Cardiol Date: 2007-04-18 Impact factor: 2.778
Authors: Allison E Aiello; Mary N Haan; Christine M Pierce; Amanda M Simanek; Jersey Liang Journal: J Gerontol A Biol Sci Med Sci Date: 2008-06 Impact factor: 6.053
Authors: Hudson P Santos; Arjun Bhattacharya; Elizabeth M Martin; Kezia Addo; Matt Psioda; Lisa Smeester; Robert M Joseph; Stephen R Hooper; Jean A Frazier; Karl C Kuban; T Michael O'Shea; Rebecca C Fry Journal: Epigenetics Date: 2019-05-21 Impact factor: 4.528
Authors: Raymond P Stowe; R Jeanne Ruiz; Christopher P Fagundes; Robin H Stowe; Min Chen; Ronald Glaser Journal: J Immunol Methods Date: 2014-05-22 Impact factor: 2.303
Authors: Antoine R Baldassari; Rebecca J Cleveland; Beth L Jonas; Doyt L Conn; Larry W Moreland; S Louis Bridges; Leigh F Callahan Journal: Arthritis Care Res (Hoboken) Date: 2014-12 Impact factor: 4.794
Authors: Aydin Nazmi; Ana V Diez-Roux; Nancy S Jenny; Michael Y Tsai; Moyses Szklo; Allison E Aiello Journal: BMC Public Health Date: 2010-11-17 Impact factor: 3.295
Authors: Allison E Aiello; Lydia Feinstein; Jennifer B Dowd; Graham Pawelec; Evelyna Derhovanessian; Sandro Galea; Monica Uddin; Derek E Wildman; Amanda M Simanek Journal: Psychosom Med Date: 2016 Jul-Aug Impact factor: 4.312